Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001968202-25-000004
Filing Date
2025-01-06
Accepted
2025-01-06 16:06:04
Documents
1
Period of Report
2025-01-02

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgardoc.html 4  
1 PRIMARY DOCUMENT edgardoc.xml 4 5577
  Complete submission text file 0001968202-25-000004.txt   7147
Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591
Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000
REGENERON PHARMACEUTICALS, INC. (Issuer) CIK: 0000872589 (see all company filings)

EIN.: 133444607 | State of Incorp.: NY | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address DEPT OF PHARMACOLOGY K5 YUVER OF TEXAS 5323 HARRY HINES BLVD DALLAS TX 75390
Business Address
GOLDSTEIN JOSEPH L (Reporting) CIK: 0001225474 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-19034 | Film No.: 25511085